Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.2.1.23 (
beta-galactosidase
)
14,648
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
This study was directed toward initial comparison and characterization of the activities of the human
steroid 21-hydroxylase
gene (CYP21) and pseudogene (CYP21P) promoters. DNA fragments containing the promoter regions of CYP21 and CYP21P were amplified and cloned into promoterless luciferase reporter plasmids either containing or lacking an enhancer element. Cells of the nonsteroidogenic COS-1 cell line, and the steroidogenic Y-1 cell line were transiently transfected with these recombinant plasmids and a
beta-galactosidase
cotransfection control plasmid. Cellular lysates were analyzed for luciferase and
beta-galactosidase
activities. In the nonsteroidogenic system, transfectants with either the CYP21 or CYP21P upstream sequence in enhancer containing plasmids showed a 2.3 fold increase (p < .001) in light production over controls. In the steroidogenic Y-1 cell system, these same CYp21 and CYP21P transfectants showed a 14.3 (+/- 0.8) and 5.2 (+/- 0.6) fold increase in luciferase activity respectively (p < .001) Transfections with recombinant reporter plasmids lacking an enhancer produced light emission which was not significantly different than controls. These observations indicate that 1.) one or more of the 35 nucleotide differences between the CYP21 and CYP21P upstream regions alters a DNA recognition site important for transcriptional activation of this gene in steroidogenic cells, 2.) the steroidogenic milieu has a stimulatory effect on both CYP21 and CYP21P promoter activities, and 3.) based on the minimal promoter activity observed in either cell type transfected with constructs lacking an enhancer element, both of these promoter sequences are enhancer dependent under constitutive conditions in both steroidogenic and nonsteroidogenic cells.
...
PMID:Constitutive human steroid 21-hydroxylase promoter gene and pseudogene activity in steroidogenic and nonsteroidogenic cells with the luciferase gene as a reporter. 858 28
The 5'-flanking regions of genes for three mouse adrenal steroid hydroxylases were analyzed for their ability to direct adrenal cortex-specific
beta-galactosidase
(beta-gal) reporter expression both in cell culture and transgenic mice. The 5'-flanking regions chosen were from the genes for
steroid 21-hydroxylase
(21-OHase), expressed throughout the adrenal cortex and mediating both glucocorticoid and mineralocorticoid synthesis, and aldosterone synthetase (AS) and steroid 11 beta-hydroxylase (11 beta-OHase), which catalyze respectively the terminal steps of mineralocorticoid synthesis in the zona glomerulosa and glucocorticoid synthesis in the zona fasciculata/reticularis. While 5.0 kb of 11 beta-OHase gene 5'-flanking region and 5.4 kb of the AS gene 5'-flanking region mediated respectively moderate and low levels of beta-gal reporter expression in Y1 adrenocortical tumor cells, neither of these 5'-flanking regions was able to direct reporter expression to the appropriate adrenocortical zone of transgenic mice. This suggests that additional regulatory elements, lying outside these 5'-flanking regions, are required for 11 beta-OHase and AS gene expression in the intact mouse. In contrast, 6.4 kb of the mouse 21-OHase A gene 5' flanking region was able to direct specific
beta-galactosidase
reporter expression, in both Y1 cells and transgenic mice, indicating that elements directing adrenal cortex-specific gene expression in vivo are located not more than 6.4 kb 5' of the 21-OHase gene transcription start site.
...
PMID:Adrenocortical-specific transgene expression directed by steroid hydroxylase gene promoters. 896 22
Unilateral adrenalectomy was used to induce compensatory growth in the contralateral adrenal gland of transgenic mice bearing a
steroid 21-hydroxylase
promoter/
beta-galactosidase
reporter (21-OHase/beta-gal) transgene, in which 6.4 kb of 5'-flanking sequence of the mouse steroid 21-OHase A gene are linked to a LacZ reporter gene. 48 hours following removal of the right adrenal gland, the left gland of transgene-positive mice showed a 4.5 fold increase in specific activity of the beta-gal reporter, compared to the right gland, while left glands from sham-operated transgene-positive and unilateral adrenalectomized transgene-negative mice showed no such increase. The increased specific transgene reporter activity, relative to total adrenal gland protein, must result from up-regulation of transgene expression, rather than from the compensatory increase in adrenocortical mass. This suggests that elements regulating trophic hormone-mediated 21-OHase gene expression in vivo are located within 6.4 kb of the 21-OHase gene transcription start site.
...
PMID:Induction of steroid 21-hydroxylase/beta-galactosidase transgene expression by unilateral adrenalectomy. 988 41